via Mercor

Hematology / Oncology Expert

Remote · Contract · $130-180/hr

About the Role

Mercor is partnering with a leading AI lab to train frontier models on high-quality healthcare reasoning data. We're hiring Hematology / Oncology experts to design clinical scenarios, evaluate model outputs against evidence-based standards, and help shape how the next generation of AI reasons about cancer and hematologic care.

We welcome Medical Oncology attendings, Hematology attendings, Surgical Oncology, Radiation Oncology, Pediatric Heme/Onc, and final-year Heme/Onc fellows.

What You'll Do

  • Design clinically realistic prompts and scenarios drawn from your Heme/Onc practice (staging, treatment selection, regimen sequencing, toxicity management, end-of-life decision-making, guideline interpretation)

  • Write "golden" reference responses at attending-level quality

  • Grade AI-generated responses against structured rubrics

  • Provide written feedback the research team uses to improve model behavior

  • Participate in onboarding office hours and specialty calibration sessions

Who You Are

  • Attending physicians: Must be board certified with current, active, unrestricted medical license

  • Resident physicians: Must be in final year of residency (recent graduates must be board-eligible)

  • Fellows: Must be board-certified/board-eligible in primary specialty and have current active, unrestricted medical license

Rates

$180–$400/hr payable, set per seniority tier (early-career → senior attending). Your specific rate is confirmed in your offer.

Engagement

  • Remote, 100% asynchronous

  • 20 hrs/wk default (can be raised after onboarding based on demand)

  • Paid weekly via Mercor

  • Start: rolling, after onboarding sign-off

  • Duration: ongoing, reviewed monthly

Before Your First Task

You'll receive an onboarding doc and a calendar invite for Onboarding Office Hours after you accept.

Listing sourced from Mercor. Annotation Academy is independent of these platforms and does not guarantee work or pay. See our disclosures.